Division of Radiology

Prof. Dr. med. Dipl.-Phys. Heinz-Peter Schlemmer

Multiparametric morphologic-functional imaging of lung cancer by CT, MR and PET/MR
© dkfz.de

The Division of Radiology at the DKFZ develops imaging methods for early detection and functional and biologic characterization of cancer using the most recent cross-sectional imaging techniques including ultrasound, dual-energy CT, MR (1.5 T, 3.0 T, 7.0 T), simultaneous PET/MR and PET/CT. Our goal is to further advance individualized diagnosis, image-guided biopsy and therapy of cancer. Methodological developments are performed in close cooperation with the other divisions of the research program and within clinical studies in collaboration with clinical partners of the Heidelberg University Hospital. For this purpose the division operates an MRI suite with two state of the art (1.5 T and 3.0 T) MR scanners the National Center for Tumor Diseases (NCT). Furthermore, the Division of Radiology is a partner of the German Consortium for Translational Oncology (DKTK) and the German Center for Lung Research. Scientific fields of application in oncology include, amongst others, prostate cancer, breast cancer, lung cancer, multiple myeloma and brain tumors. In close collaboration with the divisions of medical physics, medical informatics and radiation oncology tools for tumor diagnosis and quantification of individual therapy responses are developed and applied, to better assess changes in tissue composition during and after treatment and to perform improved quantification of therapy response. Within these collaborations further activities include computer-aided image analysis and computer assisted imaging applications for biopsy and treatment planning, e.g. for improving radiotherapy, or the detection and targeting of prostate cancer.

Contact

Prof. Dr. med. Dipl.-Phys. Heinz-Peter Schlemmer
Radiology (E010)
Deutsches Krebsforschungszentrum
Im Neuenheimer Feld 280
69120 Heidelberg
Tel: +49 6221 42 2563

Selected Publications

  • Freitag MT, Radtke JP, Afshar-Oromieh A, Roethke MC, Hadaschik BA, Gleave M, et al. Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in 68Ga-PSMA-11-PET of PET/CT and PET/MRI: comparison with mpMRI integrated in simultaneous PET/MRI. Eur J Nucl Med Mol Imaging. (2017) 44:776-787
  • Radtke JP, Wiesenfarth M, Kesch C, Freitag MT, Alt CD, Celik K, Distler F, Roth W, Wieczorek K, Stock C, Duensing S, Roethke MC, Teber D, Schlemmer HP, Hohenfellner M, Bonekamp D, Hadaschik BA. Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for Advanced Risk Modeling of Prostate Cancer-Patient-tailored Risk Stratification Can Reduce Unnecessary Biopsies. Eur Urol. 2017 Apr 8. pii: S0302-2838(17)30267-1. doi: 10.1016/j.eururo.2017.03.039. [Epub ahead of print]
  • Radbruch A, Haase R, Weberling LD, Kieslich PJ, Kickingereder P, Wick W, Schlemmer HP, Bendszus M. No signal intensity increase in the dentate nucleus on unenhanced T1-weighted MR images after more than 20 serial injections of macrocyclic gadolinium-based contrast agents. Radiology, 2017; 282(3):699-707.
  • Paech D, Schuenke P, Koehler C, Windschuh J, Mundiyanapurath S, Bickelhaupt S, Bonekamp D, Bäumer P, Bachert P, Ladd ME, Bendszus M, Wick W, Unterberg A, Schlemmer HP, Zaiss M, Radbruch A. T1-rho-weighted Dynamic Glucose-enhanced MR Imaging in the Human Brain. Radiology. 2017 Jun 16:162351. doi: 10.1148/radiol.2017162351
to top